CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-03 | Gross Jane A See Remarks | Option exercise · Restricted Stock Unit | −18,136 | 28,006 | ||
| 2018-02-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise | +25,340 | 66,623 | ||
| 2018-02-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Shares withheld for taxes | −7,514 | $3.24 | $24K | 59,109 |
| 2018-02-03 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise · Restricted Stock Unit | −25,340 | 21,385 | ||
| 2017-11-15 | Maddux Randy Joe Senior VP, Operations | Purchase | +25,000 | $2.76 | $69K | 25,000 |
Page 23 of 23 · 445 trades